Phytic acid suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum

Brain Research

Volumn 978, Issue 1-2, 2003, Pages 241-244

  Obata, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

1 Methyl 4 phenylpyridinium ion (MPP+); Fenton type reaction; Hydroxyl radical; Parkinson's disease; Phytic acid

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2,3 DIHYDROXYBENZOIC ACID; ANTIOXIDANT; HYDROXYL RADICAL; IRON; PHYTIC ACID; RINGER SOLUTION; SALICYLATE SODIUM;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR FLUID; FENTON REACTION; IRON CHELATION; MALE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

EID: 0038094460     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02830-0     Document Type: Article

References (21)

1. Chiba K., Trevor A.J., Castagnoli N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:1984;574-578.
2. Chiueh C.C., Miyake H., Peng M.T. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60:1993;251-258.
3. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
4. Floyd R.A., Watson J.J., Wong P.K. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods. 10:1984;221-235.
5. Graf E., Eaton J.W. Antioxidant functions of phytic acid. Free Radic. Biol. Med. 8:1990;61-69.
6. Graf E., Empson K.L., Eaton J.W. Phytic acid. A natural antioxidant. J. Biol Chem. 262:1987;11647-11650.
7. Halliwell B., Kaur H., Ingleman-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10:1991;439-441.
8. Hirsch E.C., Brandel J.-P., Galle P., Javoy-Agid F., Agid Y. Iron (II) and aluminium increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56:1991;446-451.
9. Maher P., Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16:1996;6394-6401.
10. Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature. 311:1984;464-746.
11. Midorikawa K., Murata M., Oikawa S., Hiraku Y., Kawanishi S. Protective effect of phytic acid on oxidative DNA damage with reference to cancer chemoprevention. Biochem. Biophys. Res. Commun. 288:2001;552-557.
12. Obata T. Dopamine efflux by MPTP and hydroxyl radical generation. J. Neural Transm. 109:2002;1159-1180.
13. Paxinos G., Watson C. The Rat Brain Stereotaxic Coordinates. 2nd Edition:1982;Academic Press, Sydney.
14. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52:1989;515-520.
15. Rimbach G., Pallauf J. Phytic acid inhibits free radical formation in vitro but does not affect liver oxidant or antioxidant status in growing rats. J. Nutr. 128:1998;1950-1955.
16. 6: a novel anti-cancer agent. Life Sci. 61:1997;343-354.
17. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. USA. 86:1989;1398-1400.
18. Stephens L.R., Hawkins P.T., Stanley A.F., Moore T., Poyner D.R., Morris P.J., Hanley M.R., Kay R.R., Irvine R.F. Myo-inositol pentakisphosphates, structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochem. J. 275:1991;485-499.
19. Tan S., Wood M., Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71:1998;95-105.
20. Van Zyl J.M., Van der Walt B.J. Apparent hydroxyl radical generation without transition metal catalysis and tyrosine nitration during oxidation of the anti-tubercular drug, isonicotinic acid hydrazide. Biochem. Pharmacol. 48:1994;2033-2042.
21. Youdim M.B.H., Ben-Shachar D., Riederer P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol. Scand. 126:1989;47-54.